ADHD Trial, Recruiting NCT06960980 Sponsor: Children's Hospital Medical Center, Cincinnati Condition: ADHD
Back to Adhd

ADHD Trial, Recruiting

NCT06960980
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 16 to 19 years old.
  • Teens who have been diagnosed with ADHD — either the mainly inattentive type or the combined type — confirmed through a structured interview called the K-SADS.
  • People who hold a valid driver's licence and spend at least 3 hours per week driving without supervision.
  • People whose IQ is 80 or above, measured using a standardised intelligence test called the KBIT-2.
  • People whose parent or guardian is willing to take part in the study alongside them.

Who may not be able to join:

  • People taking ADHD medication that cannot be paused on the days when assessments take place.
  • People who report dependence on alcohol or drugs, based on a screening questionnaire.
  • People who are currently taking psychiatric medications (such as antipsychotics or other medications that affect mood or brain function).
  • People who are prone to motion sickness in a driving simulator or virtual reality environment.
  • People with a history of moderate to severe head injury, a neurological condition, or any other condition that could affect how the brain works.
  • People who cannot see the visual tasks used in the study without wearing glasses (contact lenses are acceptable).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Jeff N Epstein, Ph.D., Children's Hospital Medical Center, Cincinnati

Phone: 513-636-0007

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
11 September 2025
Est. completion
31 August 2029

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Number of extended glances away from the roadway during simulated driving; Number of extended glances away from the roadway during simulated driving

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov